Compare HBB & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBB | LAB |
|---|---|---|
| Founded | 1904 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.2M | 326.2M |
| IPO Year | 2017 | 2008 |
| Metric | HBB | LAB |
|---|---|---|
| Price | $32.07 | $0.67 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 90.9K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ 2.75 | 0.26 |
| Revenue | ★ $606,852,000.00 | $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | $11.46 | ★ $2.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.56 | $0.63 |
| 52 Week High | $34.26 | $1.72 |
| Indicator | HBB | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 61.42 | 45.47 |
| Support Level | $17.90 | $0.63 |
| Resistance Level | $34.19 | $1.02 |
| Average True Range (ATR) | 1.04 | 0.04 |
| MACD | -0.56 | 0.01 |
| Stochastic Oscillator | 46.96 | 72.47 |
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.